Patient regrets after bilateral prophylactic mastectomy

Annals of Surgical Oncology

Volumn 5, Issue 7, 1998, Pages 603-606

  Borgen, Patrick I ^a   Hill, Arnold D K ^a   Tran, Katherine N ^a   Van Zee, Kimberly J ^a   Massie, Mary J ^a   Payne, David ^a   Biggs, Carina G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Genetics; Prophylactic mastectomy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER REGISTRY; CANCER SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 0031756591     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303829     Document Type: Article

References (12)

1. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56:265-71.
2. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
3. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risk of cancer in BRCA-1 mutation carriers. Lancet 1994;343:692-5.
4. Struewing JP, Hartge P, Wacholder S. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
5. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population based case control studies of ovarian cancer. Am J Hum Genet 1997;60:496-504.
6. Greenwald P, Nasca PC, Lawrence CE. Estimated effect of breast self examination and routine physician examinations on breast cancer mortality. N Engl J Med 1978;299:271-3.
7. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-54.
8. Bourne TH, Whitehead MI, Campbell S, Royston P, Bhan V, Collins WP. Ultrasound screening for familial ovarian cancer. Gynecol Oncol 1991;43:92-7.
9. Lerman C, Narod SA, Schulman K. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 1996;275:1885-92.
10. Hoskins KF, Stopfer JE, Calzone KA. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995;273:577-85.
11. Gross TP, Schlesselman JJ. The estimated effect of oral contraceptive use on the cumulative risk of ephithelial ovarian cancer. Obstet Gynecol 1994;83:419-24.
12. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda, MD: National Cancer Institute; 1995 (NIH publication no. 96-2789).